Indeed, prior analysis of erythrocytes in cancer patients has provided direct evidence that patient prognosis is inverse to the fraction of haemoglobin (Hb) that binds to OxPt; that is, the more haemoglobin that binds to OxPt, the worse the patient’s prognosis. Here, GSTM1 is linked to cancer.